Immune Inflammation and Disease Progression in Idiopathic Pulmonary Fibrosis
نویسندگان
چکیده
منابع مشابه
Immune Inflammation and Disease Progression in Idiopathic Pulmonary Fibrosis
The clinical course in idiopathic pulmonary fibrosis (IPF) is highly heterogeneous, with some patients having a slow progression and others an accelerated clinical and functional decline. This study aims to clinically characterize the type of progression in IPF and to investigate the pathological basis that might account for the observed differences in disease behavior. Clinical and functional ...
متن کاملPrediction of disease progression in idiopathic pulmonary fibrosis.
P Pr re ed di ic ct ti io on n o of f d di is se ea as se e p pr ro og gr re es ss si io on n i in n i id di io op pa at th hi ic c p pu ul lm mo on na ar ry y f fi ib br ro os si is s In idiopathic pulmonary fibrosis (lone cryptogenic fibrosing alveolitis (CFA)), there has been no change in survival or the frequency of responsiveness to therapy over the last two decades. Approximately 50% of p...
متن کاملProgression of idiopathic pulmonary fibrosis: lessons from asymmetrical disease.
BACKGROUND In idiopathic pulmonary fibrosis (IPF) the distribution and spatial-temporal progression of fibrotic changes may be influenced by general or locoregional conditions. From this perspective, patients with asymmetrical disease (AIPF) may be unique. METHODS This retrospective study included 32 patients (26 men, mean ± SD age 69 ± 7 years) with AIPF, as defined by an asymmetry ratio (mo...
متن کاملIdiopathic pulmonary fibrosis and coronary artery disease
Idiopathic pulmonary fibrosis (IPF) is defined as a chronic fibrosing interstitial disease of unknown cause, limited to the lungs, and associated with the histopathologic and/or radiologic pattern of usual interstitial pneumonia (UIP); it generally progresses into respiratory failure and death. Although progression of the disease is the most common cause of death, there are increasing reports o...
متن کاملEvaluating disease severity in idiopathic pulmonary fibrosis.
Accurate assessment of idiopathic pulmonary fibrosis (IPF) disease severity is integral to the care provided to patients with IPF. However, to date, there are no generally accepted or validated staging systems. There is an abundance of data on using information acquired from physiological, radiological and pathological parameters, in isolation or in combination, to assess disease severity in IP...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: PLOS ONE
سال: 2016
ISSN: 1932-6203
DOI: 10.1371/journal.pone.0154516